肥胖型多囊卵巢综合征患者63例的临床特征

The clinical features of 63 cases with obese polycystic ovary syndrome

目的:观察和探讨肥胖型多囊卵巢综合征患者的临床特点.方法:回顾性分析我院2012-12/2014-12收治的100例多囊卵巢综合征患者的临床资料,根据患者的身体特征将其中肥胖患者纳入研究组(63例),非肥胖患者纳入对照组(37例).分别对两组患者进行糖脂代谢、内分泌激素检测及常规检查和超声测量,比较两组患者的各项指标水平.结果:研究组患者的IR发生率明显高于对照组,差异有统计学意义(P<0.05).研究组患者的体重、BMI、腰围、臀围和WHR均明显高于对照组,差异均有统计学意义(P<0.05).研究组患者的LL/FSH、LH等指标明显低于对照组,差异均有统计学意义(P<0.05).结论:肥胖型多囊卵巢综合征患者的代谢症候群和内分泌异常的发生率明显高于非肥胖型多囊卵巢综合征患者,因此肥胖型患者需要注意控制自身体重,以减少远期并发症.

AIM： To observe the clinical characteristics of obesity type patients with polycystic ovary syndrome . METHODS： Analyze clinical data of 100 cases of patients with polycystic ovary syndrome retrospectively in our hospital from 2012 December to 2014 December, who were divided into study group with obese patients （63 cases） and control group with non-obese patients （37 cases） according to the physical characteristics of the patients. All patients got glucose and lipid metabolism examination, endocrine hormone detection, routine examination and ultrasonic measurement, all indexes were compared between the two groups. RESULTS： The incidence of IR in study group of patients was significantly higher than that in control group （P 〈 0.05）, with statistically significant. The weight, BMI, waistline, hipline and WHR in study group were was significantly higher than that in control group （P 〈 0.05）, the differences were statistically significant. And the LH/FSH and LH indexes in study group were was significantly higher than that in control group （P 〈 0.05）, the differences were statistical significance. CONCLUSION： The incidence of metabolic syndrome and endocrine abnormalities in obese patients with polycystic ovary syndrome are higher than that in non-obese patients. So the obese patients need to pay attention to control their weight in order to reduce long-term complications.